NZ742785A - Methods for preparing substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine - Google Patents
Methods for preparing substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amineInfo
- Publication number
- NZ742785A NZ742785A NZ742785A NZ74278516A NZ742785A NZ 742785 A NZ742785 A NZ 742785A NZ 742785 A NZ742785 A NZ 742785A NZ 74278516 A NZ74278516 A NZ 74278516A NZ 742785 A NZ742785 A NZ 742785A
- Authority
- NZ
- New Zealand
- Prior art keywords
- phenylbenzo
- isoquinolin
- dihydro
- amine
- methods
- Prior art date
Links
- IKLWZGVCUZDMEL-UHFFFAOYSA-N 6-phenyl-5,6-dihydrobenzo[f]isoquinolin-2-amine Chemical class C1=NC(N)=CC(C2=CC=CC=C22)=C1CC2C1=CC=CC=C1 IKLWZGVCUZDMEL-UHFFFAOYSA-N 0.000 title 1
- -1 (substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine) dihydrochloride salt Chemical class 0.000 abstract 1
- 229940126062 Compound A Drugs 0.000 abstract 1
- 102100023600 Fibroblast growth factor receptor 2 Human genes 0.000 abstract 1
- 101710182389 Fibroblast growth factor receptor 2 Proteins 0.000 abstract 1
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 abstract 1
- 230000035755 proliferation Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
- C07D239/84—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562268758P | 2015-12-17 | 2015-12-17 | |
| PCT/US2016/067161 WO2017106639A1 (en) | 2015-12-17 | 2016-12-16 | Methods for preparing substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ742785A true NZ742785A (en) | 2023-06-30 |
Family
ID=59057623
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ742785A NZ742785A (en) | 2015-12-17 | 2016-12-16 | Methods for preparing substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine |
Country Status (16)
| Country | Link |
|---|---|
| US (4) | US9834519B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP4015508A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP6940504B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20180085814A (cg-RX-API-DMAC7.html) |
| CN (2) | CN108602779A (cg-RX-API-DMAC7.html) |
| AU (2) | AU2016369520B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112018012325A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3006077A1 (cg-RX-API-DMAC7.html) |
| EA (1) | EA201891431A1 (cg-RX-API-DMAC7.html) |
| HK (1) | HK1255014A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL259557A (cg-RX-API-DMAC7.html) |
| MX (2) | MX385672B (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ742785A (cg-RX-API-DMAC7.html) |
| SG (1) | SG11201804601TA (cg-RX-API-DMAC7.html) |
| TW (1) | TWI748972B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2017106639A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112018012095A2 (pt) | 2015-12-17 | 2018-11-27 | Arqule Inc | formas sólidas de compostos substituidos de 5,6-di-hidro-6-fenilbenzo[f]isoquinolin-2-amina |
| EP4015508A1 (en) * | 2015-12-17 | 2022-06-22 | ArQule, Inc. | Methods for preparing substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine |
| CN110669015A (zh) * | 2018-07-03 | 2020-01-10 | 上海喀露蓝科技有限公司 | 一种fgfr抑制剂的制备方法 |
| US10878412B2 (en) * | 2019-05-13 | 2020-12-29 | Truist Bank | In-line verification of transactions |
| WO2022053708A1 (en) | 2020-09-14 | 2022-03-17 | Basilea Pharmaceutica International AG | Pharmaceutical combinations for use in the treatment of gastric adenocarcinoma |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| EP0946523A1 (en) * | 1996-12-23 | 1999-10-06 | Celltech Therapeutics Limited | Fused polycyclic 2-aminopyrimidine derivatives, their preparation and their use as protein tyrosine kinase inhibitors |
| GB9713087D0 (en) * | 1997-06-20 | 1997-08-27 | Celltech Therapeutics Ltd | Chemical compounds |
| WO2006066172A1 (en) | 2004-12-17 | 2006-06-22 | Amgen, Inc. | Aminopyrimidine compounds and methods of use |
| AU2007342007A1 (en) | 2006-12-29 | 2008-07-10 | Rigel Pharmaceuticals, Inc. | Substituted triazoles useful as Axl inhibitors |
| GB2449293A (en) * | 2007-05-17 | 2008-11-19 | Evotec | Compounds having Hsp90 inhibitory activity |
| KR101714799B1 (ko) * | 2008-12-30 | 2017-03-09 | 아르퀼 인코포레이티드 | 치환된 5,6-디히드로-6-페닐벤조［ｆ］이소퀴놀린-2-아민 화합물 |
| CN103476770B (zh) | 2010-11-25 | 2017-02-15 | 拉蒂欧制药有限责任公司 | 阿法替尼盐和多晶型物 |
| US8815854B2 (en) * | 2011-06-24 | 2014-08-26 | Arqule, Inc. | Substituted imidazopyridinyl compounds |
| CN106459993A (zh) * | 2014-03-31 | 2017-02-22 | 德彪药业国际股份公司 | Fgfr融合体 |
| BR112018012095A2 (pt) | 2015-12-17 | 2018-11-27 | Arqule Inc | formas sólidas de compostos substituidos de 5,6-di-hidro-6-fenilbenzo[f]isoquinolin-2-amina |
| EP4015508A1 (en) | 2015-12-17 | 2022-06-22 | ArQule, Inc. | Methods for preparing substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine |
-
2016
- 2016-12-16 EP EP21216064.2A patent/EP4015508A1/en active Pending
- 2016-12-16 KR KR1020187020433A patent/KR20180085814A/ko not_active Ceased
- 2016-12-16 BR BR112018012325A patent/BR112018012325A2/pt not_active Application Discontinuation
- 2016-12-16 CN CN201680081965.5A patent/CN108602779A/zh active Pending
- 2016-12-16 SG SG11201804601TA patent/SG11201804601TA/en unknown
- 2016-12-16 TW TW105141874A patent/TWI748972B/zh not_active IP Right Cessation
- 2016-12-16 WO PCT/US2016/067161 patent/WO2017106639A1/en not_active Ceased
- 2016-12-16 CA CA3006077A patent/CA3006077A1/en active Pending
- 2016-12-16 US US15/381,418 patent/US9834519B2/en active Active
- 2016-12-16 HK HK18114135.7A patent/HK1255014A1/zh unknown
- 2016-12-16 CN CN202210565751.2A patent/CN114874149A/zh active Pending
- 2016-12-16 MX MX2018007415A patent/MX385672B/es unknown
- 2016-12-16 JP JP2018531343A patent/JP6940504B2/ja not_active Expired - Fee Related
- 2016-12-16 MX MX2020012771A patent/MX2020012771A/es unknown
- 2016-12-16 AU AU2016369520A patent/AU2016369520B2/en not_active Ceased
- 2016-12-16 NZ NZ742785A patent/NZ742785A/en not_active IP Right Cessation
- 2016-12-16 EP EP16876767.1A patent/EP3390368A4/en not_active Withdrawn
- 2016-12-16 EA EA201891431A patent/EA201891431A1/ru unknown
-
2017
- 2017-11-01 US US15/800,648 patent/US10093632B2/en active Active
-
2018
- 2018-05-23 IL IL259557A patent/IL259557A/en unknown
-
2019
- 2019-04-22 US US16/390,205 patent/US10766868B2/en not_active Expired - Fee Related
- 2019-10-03 US US16/592,003 patent/US11279679B2/en active Active
-
2021
- 2021-04-28 AU AU2021202610A patent/AU2021202610B2/en not_active Ceased
- 2021-09-02 JP JP2021142864A patent/JP2021191782A/ja not_active Ceased
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202001717B (en) | Compounds, salts thereof and methods for treatment of diseases | |
| PH12019501321A1 (en) | Methods of treating or preventing cholesterol related disorders | |
| PH12019550235A1 (en) | Kinase inhibitors and uses thereof | |
| MX2017016363A (es) | Fenoxifenilamidinas sustituidas con halogeno y el uso de estas como fungicidas. | |
| MX2015012478A (es) | Metodos y composiciones para inhibicion de proteinas que contienen bromodominio. | |
| EP3778605A3 (en) | Lrrk2 inhibitors and methods of making and using the same | |
| MX2021013118A (es) | Compuestos polifluorados que actuan como inhibidores de la tirosina cinasa de bruton. | |
| TW201613886A (en) | 3-amino-1,5,6,7-tetrahydro-4h-indol-4-ones | |
| MX2016012829A (es) | Inhibidores de biaril cinasa. | |
| NZ731287A (en) | Synthesis of copanlisib and its dihydrochloride salt | |
| JO3487B1 (ar) | تخليق كوبانليسيب وملح الدايهيدروكلوريد الخاص به | |
| NZ742785A (en) | Methods for preparing substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine | |
| CR20200154A (es) | Enantiómeros de tiazoles sustituidos como compuestos antivirales | |
| MX2016008898A (es) | Antagonistas selectivos de nr2b. | |
| IN2014MU00455A (cg-RX-API-DMAC7.html) | ||
| ZA201606471B (en) | Antimitotic amides for the treatment of cancer and proliferative disorders | |
| PH12014501712A1 (en) | Novel morpholinyl derivatives useful as mogat-2-inhibitors | |
| MY177465A (en) | A microorganism of the genus escherichia producing l-tryptophan and a method for producing l-tryptophan using the same | |
| NZ730816A (en) | Quinoline carboxamides for use in the treatment of multiple myeloma | |
| NZ725417A (en) | New sulfonylaminobenzamide compounds | |
| PL3484855T3 (pl) | Nowy związek benzyloamidowy, sposób jego wytwarzania i środek roztoczobójczy | |
| PT3722282T (pt) | Forma de sal e forma cristalina que servem como compostos inibidores de fgfr e vegfr, e método de preparação para esse fim | |
| MX383313B (es) | Compuestos de quinolinilciclohexilpropanamida sustituidos y metodos mejorados para su preparacion | |
| ZA201803105B (en) | Industrial process for the preparation of (5s,10s)-10-benzyl-16-methyl-11,14,18-trioxo-15,17,19-trioxa-2,7,8-trithia-12-azahenicosan-5-aminium (e)-3-carboxyacrylate salt | |
| MX2018004256A (es) | Antagonistas de receptor de n-metil-d-aspartato subtipo 2b (nr2b) selectivos. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| LAPS | Patent lapsed |